Navigation Links
Pharmacyclics Reports CLL Results from Preclinical and Clinical Studies of its Btk Inhibitor PCI-32765
Date:12/5/2010

phocytosis may achieve a PR by standard response criteria with continued therapy.

(Photo: http://photos.prnewswire.com/prnh/20101205/SF12271)

Based on the pooled analysis from the Phase Ia study (~8 months median follow-up) and the Ib/II study (<2 months median follow-up) in this group of CLL/SLL patients, of the 45 evaluable patients, one patient achieved a CR (2%), 16 (36%) achieved a PR and an additional 19 (42%) have experienced a dramatic reduction in lymph node disease with lymphocytosis. When evaluating nodal disease alone, 87% percent (34 out of 39) of patients achieved a 50% or greater reduction in lymph node burden.  In patients with symptomatic disease, this early response was often associated with improvement in symptoms.

PCI-32765 continues to be well tolerated in this patient population.  Grade 3/4 events were uncommon. More common grade1/2 events were diarrhea and other GI and constitutional symptoms.  No hepatic or renal laboratory adverse events were reported on this trial and significant hematologic events were infrequent. There was no evidence of cumulative toxicity.

ASH Conference Call and Webcast Details:Date: Wednesday, December 8, 2010Time: 4:30 pm ETSlides used in Presentation: http://ir.pharmacyclics.com/events.cfm Listen via Internet: http://ir.pharmacyclics.com/events.cfm Live Participant Dial In (Toll Free): 877-407-8133 Live Participant Dial In (International): 201-689-8040 To access the live audio broadcast or the subsequent archived recording, log on to http://ir.pharmacyclics.com/events.cfm. The archived version of the webcast will be available for 30 days on the Investor Relations section of the company's Web site at www.pha
'/>"/>

SOURCE Pharmacyclics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010
2. Pharmacyclics Announces Date of Fiscal Year End 2010 Financial Results and Conference Call and Presentation at Stifel Nicolaus Healthcare Conference
3. Pharmacyclics to Present at Bank of America Merrill Lynch Healthcare Conference and MDB Bright Lights Conference
4. Pharmacyclics to Present at the RBC Capital Markets Healthcare Investor Conference
5. Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results
6. Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7
7. Pharmacyclics Announces Poster Presentations and Clinical Update at the 51st Annual Meeting of the American Society of Hematology
8. Pharmacyclics to Present at Merriman Curhan Fords Investor Summit 2009
9. Pharmacyclics announces Global Strategic Alliance with Les Laboratoires Servier
10. Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkins Lymphoma
11. Pharmacyclics, Inc. Announces Closing of a Private Financing With the Principals of Pacific Biopharma Group, Ltd.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... According to a new market research ... Spinal Cord Stimulation, Transcranial Magnetic Stimulation), Application (Depression, Parkinson,s, Tinnitus, ... published by MarketsandMarkets, the global Neuromodulation Market is estimated at ... Billion by 2020, at a CAGR of 11.2% during the ... 4 market data T ables and ...
(Date:7/2/2015)... HILL, Conn. , July 2, 2015 ... Chief Executive Officer announced that Tamas Feitel ... Feitel joins Numotion after a highly successful 18 ... finance leadership roles driving strategy, profitability, and productivity to ... His most recent position was Chief Financial Officer for ...
(Date:7/2/2015)... DUBLIN , June 25, 2015 /PRNewswire/ ... http://www.researchandmarkets.com/research/8mfjxh/2015_new ) has announced the addition of ... Chemistry and Immunodiagnostics: Global Challenges, Emerging Technologies, ... 2015 New Frontiers in Clinical ... Competitive Landscape is a new seven-country strategic ...
Breaking Medicine Technology:Neuromodulation Market Worth $6.20 Billion by 2020 2Neuromodulation Market Worth $6.20 Billion by 2020 3Neuromodulation Market Worth $6.20 Billion by 2020 4Numotion Names Tamas Feitel Chief Financial Officer 2New Frontiers in 2015 Global Clinical Chemistry and Immunodiagnostics Market: Challenges, Emerging Technologies, Competitive Landscape 2
(Date:7/4/2015)... ... 04, 2015 , ... Tyler Boden, Project Developer of Sullivan ... from the North American Board of Certified Energy Practitioners (NABCEP®), and is now ... and well established national certification organization for renewable energy professionals. Designation as a ...
(Date:7/3/2015)... ... 03, 2015 , ... On June 30th SEO authority and ... system called "Page One Engine" . The program, which has been hailed ... from several well-known marketers. HonestyFirstReviews.com's Tiffany Hendricks has joined the party, publishing an ...
(Date:7/3/2015)... ... ... Renowned rhinoplasty surgeon and Symposium Chairman, Dr. Rod J. Rohrich ... be held from March 4th - 6th, the 2016 (a previous announcement had stated ... Designed to take participants from the basic training and fundamentals of nasal surgery through ...
(Date:7/3/2015)... ... July 03, 2015 , ... The Erie ... 25, 2015 at 1:00pm. The Association welcomed speaker C. Daniel McGillicuddy Esq. of ... and practical points of investigating these types of cases. , Each year, New ...
(Date:7/3/2015)... , ... July 03, 2015 , ... Jennifer Renee Hanes, ... Choice Emergency Room , the largest network of independent freestanding emergency rooms in the ... medical director of our Sienna Plantation facility,” said Executive Medical Director of First Choice ...
Breaking Medicine News(10 mins):Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3Health News:Page One Engine - Review Of Dori Friend's SEO Training Course Released 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 3
... and Peter Goss have given their resignations with three ... a full time replacement is not expected for at ... concerns among obstetricians at Sale. Sale obstetrician Dr Refaat ... to deliver premature babies without pediatric support. ...
... was initiated by Quebec Health Minister Philippe Couillard on Thursday ... //. ,The Supreme Court of Canada decision had ... 9, 2005,ruling that Quebec had failed to prove its ban ... justified. However with the development of Bill 33, proposed ...
... Anbumani Ramadoss Friday warned of "strong action" against "indiscipline" ... Institute of Medical Sciences// (AIIMS), saying a coterie had ... ,"Some people have converted the AIIMS into a political ... I return to New Delhi June 19," Ramadoss told ...
... the Karolinska Institutet they have found ways to control the ... intestinal stem cell. The result of the study was published ... help in the development of new drugs for diseases such ... body, old cells are continually being replaced by new. If ...
... a report www.bmj.com which speaks of the enhanced risk of ... diabetes. // They have cautioned that worse problems are in ... improvement. ,Researchers analyzed deaths shortly after birth (perinatal mortality) ... 1 or type 2 diabetes who delivered between 1 March ...
... Most Common Human Disease,Tooth, decay,prevalent,disease, stroke, information, dental, scientific, oral ... most prevalent of human diseases // or ... or that dental diseases could play a role in ... are but a few of the thousands of pieces of ...
Cached Medicine News:Health News:Quebecers To Choose Private Health-Care Insurance 2Health News:Mechanism of Stem Cell Regulation Identified 2Health News:Diabetic women may suffer a complicated pregnancy 2Health News:Tooth Deccay is Still The Most Common Human Disease 2Health News:Tooth Deccay is Still The Most Common Human Disease 3Health News:Tooth Deccay is Still The Most Common Human Disease 4
... Aisys Carestation helps you deliver unmatched performance ... Carestation is the most complete anesthesia solution ... of need - at your fingertips., ... industry-leading Datex-Ohmeda legacy of anesthesia delivery and ...
... Mesh Elastic is a lightweight and large pore ... mesh is able to adapt to all movements ... honeycomb like structure with the large pores enables ... The mesh is ideal for incisional hernia repair ...
... Premilene Mesh, made from monofilament polypropylene, is ... of the chest wall. The monofilaments are ... mesh. Premilene Mesh is characterized by the ... It adapts optimally to movements of the ...
... advanced optical system of the Applied Fiberoptics ... illumination. There are six models to choose ... options. Spot size ranges from 15 mm ... system is compatible with any of our ...
Medicine Products: